ID
15350
Beschrijving
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Trefwoorden
Versies (5)
- 13-08-15 13-08-15 - Martin Dugas
- 23-05-16 23-05-16 -
- 28-05-16 28-05-16 -
- 28-05-16 28-05-16 -
- 06-06-16 06-06-16 -
Geüploaded op
28 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0 Legacy
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Beschrijving
Trial Medication RQG
Beschrijving
Date of Administration
Datatype
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
Beschrijving
Trial Medication: Dose administered
Datatype
float
Maateenheden
- mg
Alias
- UMLS CUI [1]
- C3174092
Beschrijving
Trial Medication: Batch No
Datatype
text
Alias
- UMLS CUI [1]
- C3641829
Beschrijving
Expiration
Datatype
date
Alias
- UMLS CUI [1]
- C3669020
Beschrijving
Trial Medication: Reason if less than 12 mg
Datatype
text
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0392360
Similar models
Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
C0947611 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
C0243095 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1705848 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])